Frequencies for first 10,000 rows of indi_pt variable in indi2008q1 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- 5Q-SYNDROME | 1 0.01 0.01 ABDOMINAL PAIN | 9 0.09 0.10 ABDOMINAL PAIN UPPER | 5 0.05 0.15 ABNORMAL BEHAVIOUR | 2 0.02 0.17 ABORTION | 3 0.03 0.20 ACCIDENTAL EXPOSURE | 1 0.01 0.21 ACNE | 49 0.49 0.70 ACNE CYSTIC | 3 0.03 0.73 ACOUSTIC NEUROMA | 1 0.01 0.74 ACQUIRED IMMUNODEFICIENCY SYNDROME | 18 0.18 0.92 ACROMEGALY | 1 0.01 0.93 ACTINIC KERATOSIS | 1 0.01 0.94 ACUTE CORONARY SYNDROME | 10 0.10 1.04 ACUTE HEPATIC FAILURE | 1 0.01 1.05 ACUTE LEUKAEMIA | 2 0.02 1.07 ACUTE LYMPHOCYTIC LEUKAEMIA | 37 0.37 1.44 ACUTE MYELOID LEUKAEMIA | 15 0.15 1.59 ACUTE MYELOID LEUKAEMIA RECURRENT | 5 0.05 1.64 ACUTE MYOCARDIAL INFARCTION | 9 0.09 1.73 ACUTE PROMYELOCYTIC LEUKAEMIA | 4 0.04 1.77 ACUTE PSYCHOSIS | 2 0.02 1.79 ADENOCARCINOMA | 5 0.05 1.84 ADENOCARCINOMA PANCREAS | 2 0.02 1.86 ADRENAL INSUFFICIENCY | 1 0.01 1.87 ADVERSE DRUG REACTION | 2 0.02 1.89 ADVERSE EVENT | 3 0.03 1.92 AFFECTIVE DISORDER | 5 0.05 1.97 AGGRESSION | 1 0.01 1.98 AGITATED DEPRESSION | 1 0.01 1.99 AGITATION | 7 0.07 2.06 AGRANULOCYTOSIS | 2 0.02 2.08 ALCOHOL ABUSE | 2 0.02 2.10 ALLERGIC BRONCHITIS | 1 0.01 2.11 ALLERGIC TRANSFUSION REACTION | 1 0.01 2.12 ALLERGY TEST | 1 0.01 2.13 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 3 0.03 2.16 ANAEMIA | 10 0.10 2.26 ANAEMIA OF MALIGNANT DISEASE | 3 0.03 2.29 ANAEMIA POSTOPERATIVE | 1 0.01 2.30 ANAESTHESIA | 12 0.12 2.42 ANAL CANCER | 1 0.01 2.43 ANALGESIA | 13 0.13 2.56 ANALGESIC THERAPY | 3 0.03 2.59 ANAPHYLACTIC REACTION | 1 0.01 2.60 ANGER | 1 0.01 2.61 ANGINA PECTORIS | 15 0.15 2.76 ANGINA UNSTABLE | 2 0.02 2.78 ANGIOGRAM | 4 0.04 2.82 ANGIOGRAM CEREBRAL | 2 0.02 2.84 ANGIOGRAM PERIPHERAL | 1 0.01 2.85 ANGIOPLASTY | 7 0.07 2.92 ANGIOSARCOMA | 1 0.01 2.93 ANKYLOSING SPONDYLITIS | 19 0.19 3.12 ANOREXIA | 7 0.07 3.19 ANTACID THERAPY | 3 0.03 3.22 ANTIALLERGIC THERAPY | 2 0.02 3.24 ANTIBIOTIC PROPHYLAXIS | 12 0.12 3.36 ANTIBIOTIC THERAPY | 3 0.03 3.39 ANTICOAGULANT THERAPY | 19 0.19 3.58 ANTIDEPRESSANT THERAPY | 2 0.02 3.60 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.61 ANTIFUNGAL PROPHYLAXIS | 10 0.10 3.71 ANTIINFLAMMATORY THERAPY | 1 0.01 3.72 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 3.73 ANTIRETROVIRAL THERAPY | 3 0.03 3.76 ANTITUSSIVE THERAPY | 2 0.02 3.78 ANTIVIRAL PROPHYLAXIS | 14 0.14 3.92 ANXIETY | 81 0.81 4.73 ANXIETY DISORDER | 4 0.04 4.77 ANXIOLYTIC THERAPY | 2 0.02 4.79 AORTIC VALVE REPLACEMENT | 1 0.01 4.80 APHERESIS | 2 0.02 4.82 APPETITE DISORDER | 1 0.01 4.83 ARRHYTHMIA | 12 0.12 4.95 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 4.96 ARTERIAL STENT INSERTION | 1 0.01 4.97 ARTERIOGRAM | 2 0.02 4.99 ARTERIOSCLEROSIS | 1 0.01 5.00 ARTERIOSCLEROSIS OBLITERANS | 2 0.02 5.02 ARTERITIS | 1 0.01 5.03 ARTHRALGIA | 36 0.36 5.39 ARTHRITIS | 22 0.22 5.61 ARTHRITIS INFECTIVE | 1 0.01 5.62 ARTIFICIAL MENOPAUSE | 1 0.01 5.63 ASTHMA | 133 1.33 6.96 ASTROCYTOMA | 3 0.03 6.99 ASTROCYTOMA, LOW GRADE | 3 0.03 7.02 ATRIAL FIBRILLATION | 47 0.47 7.49 ATRIAL FLUTTER | 3 0.03 7.52 ATRIAL SEPTAL DEFECT REPAIR | 1 0.01 7.53 ATRIAL TACHYCARDIA | 3 0.03 7.56 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 18 0.18 7.74 AUTISM SPECTRUM DISORDER | 1 0.01 7.75 AUTOIMMUNE THYROIDITIS | 1 0.01 7.76 B-CELL LYMPHOMA | 27 0.27 8.03 BACK DISORDER | 2 0.02 8.05 BACK PAIN | 72 0.72 8.77 BACTERIAL INFECTION | 2 0.02 8.79 BARIUM ENEMA | 2 0.02 8.81 BARIUM MEAL | 2 0.02 8.83 BARIUM SWALLOW | 4 0.04 8.87 BASAL CELL CARCINOMA | 1 0.01 8.88 BEHCET'S SYNDROME | 2 0.02 8.90 BENIGN PROSTATIC HYPERPLASIA | 24 0.24 9.14 BILE DUCT CANCER | 2 0.02 9.16 BILE DUCT CANCER STAGE III | 1 0.01 9.17 BILE DUCT STONE | 1 0.01 9.18 BIPOLAR DISORDER | 48 0.48 9.66 BIPOLAR I DISORDER | 8 0.08 9.74 BLADDER CANCER | 4 0.04 9.78 BLADDER CATHETERISATION | 1 0.01 9.79 BLADDER DISORDER | 1 0.01 9.80 BLADDER NECK OBSTRUCTION | 1 0.01 9.81 BLADDER SPASM | 1 0.01 9.82 BLOOD ANTIDIURETIC HORMONE | 1 0.01 9.83 BLOOD BILIRUBIN INCREASED | 3 0.03 9.86 BLOOD CALCIUM DECREASED | 1 0.01 9.87 BLOOD CHOLESTEROL | 14 0.14 10.01 BLOOD CHOLESTEROL ABNORMAL | 1 0.01 10.02 BLOOD CHOLESTEROL INCREASED | 40 0.40 10.42 BLOOD DISORDER | 1 0.01 10.43 BLOOD GLUCOSE | 2 0.02 10.45 BLOOD GLUCOSE INCREASED | 1 0.01 10.46 BLOOD GROWTH HORMONE DECREASED | 1 0.01 10.47 BLOOD HOMOCYSTEINE INCREASED | 2 0.02 10.49 BLOOD IRON INCREASED | 1 0.01 10.50 BLOOD MAGNESIUM DECREASED | 2 0.02 10.52 BLOOD OESTROGEN | 1 0.01 10.53 BLOOD PHOSPHORUS INCREASED | 1 0.01 10.54 BLOOD PRESSURE | 16 0.16 10.70 BLOOD PRESSURE ABNORMAL | 2 0.02 10.72 BLOOD PRESSURE INCREASED | 8 0.08 10.80 BLOOD PRESSURE MANAGEMENT | 1 0.01 10.81 BLOOD TESTOSTERONE DECREASED | 3 0.03 10.84 BONE DENSITY DECREASED | 3 0.03 10.87 BONE DISORDER | 7 0.07 10.94 BONE MARROW CONDITIONING REGIMEN | 5 0.05 10.99 BONE MARROW TRANSPLANT | 1 0.01 11.00 BONE OPERATION | 1 0.01 11.01 BONE PAIN | 5 0.05 11.06 BORDERLINE PERSONALITY DISORDER | 1 0.01 11.07 BRAIN ABSCESS | 1 0.01 11.08 BRAIN NEOPLASM | 1 0.01 11.09 BRAIN OEDEMA | 1 0.01 11.10 BREAKTHROUGH PAIN | 10 0.10 11.20 BREAST CANCER | 80 0.80 12.00 BREAST CANCER FEMALE | 6 0.06 12.06 BREAST CANCER METASTATIC | 26 0.26 12.32 BREAST CANCER STAGE IV | 5 0.05 12.37 BRONCHIAL CARCINOMA | 2 0.02 12.39 BRONCHIAL DISORDER | 5 0.05 12.44 BRONCHIAL OBSTRUCTION | 4 0.04 12.48 BRONCHIECTASIS | 1 0.01 12.49 BRONCHITIS | 40 0.40 12.89 BRONCHITIS CHRONIC | 15 0.15 13.04 BRONCHOPNEUMONIA | 5 0.05 13.09 BRONCHOPULMONARY ASPERGILLOSIS | 6 0.06 13.15 BURKITT'S LYMPHOMA | 11 0.11 13.26 BURN INFECTION | 1 0.01 13.27 BURNING SENSATION | 2 0.02 13.29 BURSITIS | 1 0.01 13.30 CACHEXIA | 1 0.01 13.31 CAESAREAN SECTION | 1 0.01 13.32 CAMPYLOBACTER INFECTION | 1 0.01 13.33 CANCER IN REMISSION | 1 0.01 13.34 CANCER PAIN | 11 0.11 13.45 CANDIDIASIS | 3 0.03 13.48 CARCINOID SYNDROME | 1 0.01 13.49 CARDIAC DISORDER | 20 0.20 13.69 CARDIAC FAILURE | 12 0.12 13.81 CARDIAC FAILURE CHRONIC | 5 0.05 13.86 CARDIAC FAILURE CONGESTIVE | 10 0.10 13.96 CARDIAC OPERATION | 1 0.01 13.97 CARDIAC VALVE PROSTHESIS USER | 3 0.03 14.00 CARDIO-RESPIRATORY ARREST | 1 0.01 14.01 CARDIOVASCULAR DISORDER | 2 0.02 14.03 CARDIOVASCULAR EVENT PROPHYLAXIS | 6 0.06 14.09 CAROTID ARTERY STENOSIS | 3 0.03 14.12 CAROTID ENDARTERECTOMY | 1 0.01 14.13 CASTLEMAN'S DISEASE | 1 0.01 14.14 CAT SCRATCH DISEASE | 1 0.01 14.15 CATARACT OPERATION | 43 0.43 14.58 CELLULITIS | 4 0.04 14.62 CENTRAL PAIN SYNDROME | 2 0.02 14.64 CEREBRAL INFARCTION | 15 0.15 14.79 CEREBRAL ISCHAEMIA | 1 0.01 14.80 CEREBRAL TOXOPLASMOSIS | 2 0.02 14.82 CEREBROVASCULAR ACCIDENT | 10 0.10 14.92 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 5 0.05 14.97 CERUMEN REMOVAL | 2 0.02 14.99 CERVIX CARCINOMA | 6 0.06 15.05 CHEMOTHERAPY | 22 0.22 15.27 CHEST DISCOMFORT | 4 0.04 15.31 CHEST PAIN | 1 0.01 15.32 CHILLS | 1 0.01 15.33 CHOLANGITIS ACUTE | 1 0.01 15.34 CHOLECYSTECTOMY | 1 0.01 15.35 CHOLELITHIASIS | 1 0.01 15.36 CHRONIC HEPATITIS | 1 0.01 15.37 CHRONIC LEUKAEMIA | 1 0.01 15.38 CHRONIC LYMPHOCYTIC LEUKAEMIA | 39 0.39 15.77 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFO.. | 5 0.05 15.82 CHRONIC MYELOID LEUKAEMIA | 21 0.21 16.03 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 170 1.70 17.73 CHRONIC SINUSITIS | 3 0.03 17.76 CIRRHOSIS ALCOHOLIC | 1 0.01 17.77 CLOSTRIDIAL INFECTION | 1 0.01 17.78 COAGULOPATHY | 1 0.01 17.79 COLITIS | 5 0.05 17.84 COLITIS ULCERATIVE | 22 0.22 18.06 COLON CANCER | 22 0.22 18.28 COLON CANCER METASTATIC | 14 0.14 18.42 COLONOSCOPY | 2 0.02 18.44 COLORECTAL CANCER | 32 0.32 18.76 COLORECTAL CANCER METASTATIC | 18 0.18 18.94 COMPUTERISED TOMOGRAM | 11 0.11 19.05 COMPUTERISED TOMOGRAM ABDOMEN | 4 0.04 19.09 COMPUTERISED TOMOGRAM THORAX | 1 0.01 19.10 CONFUSIONAL STATE | 1 0.01 19.11 CONGENITAL APLASTIC ANAEMIA | 1 0.01 19.12 CONJUNCTIVITIS | 1 0.01 19.13 CONSTIPATION | 36 0.36 19.49 CONSTIPATION PROPHYLAXIS | 3 0.03 19.52 CONTRACEPTION | 86 0.86 20.38 CONVULSION | 42 0.42 20.80 CORD BLOOD TRANSPLANT THERAPY | 1 0.01 20.81 CORNEAL DEFECT | 1 0.01 20.82 CORONARY ANGIOPLASTY | 3 0.03 20.85 CORONARY ARTERIAL STENT INSERTION | 1 0.01 20.86 CORONARY ARTERY DISEASE | 20 0.20 21.06 CORONARY ARTERY OCCLUSION | 1 0.01 21.07 COUGH | 12 0.12 21.19 CROHN'S DISEASE | 70 0.70 21.89 CRYPTOGENIC ORGANISING PNEUMONIA | 1 0.01 21.90 CYSTITIS | 9 0.09 21.99 CYSTITIS INTERSTITIAL | 1 0.01 22.00 CYSTITIS NONINFECTIVE | 1 0.01 22.01 CYSTOPEXY | 1 0.01 22.02 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 22.03 CYTOMEGALOVIRUS INFECTION | 1 0.01 22.04 DANDRUFF | 1 0.01 22.05 DECREASED APPETITE | 1 0.01 22.06 DECUBITUS ULCER | 1 0.01 22.07 DEEP VEIN THROMBOSIS | 15 0.15 22.22 DEHYDRATION | 2 0.02 22.24 DELIRIUM | 1 0.01 22.25 DELUSION | 3 0.03 22.28 DEMENTIA | 4 0.04 22.32 DEMENTIA ALZHEIMER'S TYPE | 28 0.28 22.60 DENTAL CARE | 2 0.02 22.62 DENTAL CLEANING | 1 0.01 22.63 DENTAL DISORDER PROPHYLAXIS | 3 0.03 22.66 DENTAL PLAQUE | 1 0.01 22.67 DEPRESSED MOOD | 1 0.01 22.68 DEPRESSION | 238 2.38 25.06 DERMATITIS | 6 0.06 25.12 DERMATITIS ATOPIC | 3 0.03 25.15 DERMATITIS CONTACT | 6 0.06 25.21 DERMATITIS EXFOLIATIVE | 2 0.02 25.23 DEVICE RELATED INFECTION | 2 0.02 25.25 DIABETES INSIPIDUS | 1 0.01 25.26 DIABETES MELLITUS | 138 1.38 26.64 DIABETIC FOOT INFECTION | 1 0.01 26.65 DIABETIC NEUROPATHY | 4 0.04 26.69 DIAGNOSTIC PROCEDURE | 2 0.02 26.71 DIALYSIS | 1 0.01 26.72 DIARRHOEA | 10 0.10 26.82 DIFFUSE LARGE B-CELL LYMPHOMA STAGE II | 4 0.04 26.86 DIURETIC THERAPY | 6 0.06 26.92 DIVERTICULAR PERFORATION | 2 0.02 26.94 DIVERTICULITIS | 2 0.02 26.96 DIVERTICULUM | 1 0.01 26.97 DIZZINESS | 5 0.05 27.02 DRUG ABUSE | 1 0.01 27.03 DRUG DEPENDENCE | 2 0.02 27.05 DRUG DIVERSION | 1 0.01 27.06 DRUG EFFECT DECREASED | 1 0.01 27.07 DRUG EXPOSURE DURING PREGNANCY | 29 0.29 27.36 DRUG INEFFECTIVE | 1 0.01 27.37 DRUG THERAPY | 6 0.06 27.43 DRUG TOXICITY PROPHYLAXIS | 1 0.01 27.44 DRUG USE FOR UNKNOWN INDICATION | 1,548 15.48 42.92 DRUG WITHDRAWAL SYNDROME | 1 0.01 42.93 DRY EYE | 5 0.05 42.98 DUODENAL ULCER | 4 0.04 43.02 DYSLIPIDAEMIA | 6 0.06 43.08 DYSMENORRHOEA | 4 0.04 43.12 DYSPAREUNIA | 1 0.01 43.13 DYSPEPSIA | 23 0.23 43.36 DYSPHAGIA | 1 0.01 43.37 DYSPNOEA | 33 0.33 43.70 DYSTHYMIC DISORDER | 6 0.06 43.76 DYSURIA | 1 0.01 43.77 EAR DISORDER | 1 0.01 43.78 EAR INFECTION | 3 0.03 43.81 EAR PAIN | 1 0.01 43.82 EAR, NOSE AND THROAT EXAMINATION ABNO.. | 1 0.01 43.83 EATING DISORDER | 8 0.08 43.91 ECZEMA | 1 0.01 43.92 EISENMENGER'S SYNDROME | 1 0.01 43.93 ELECTROCARDIOGRAM ABNORMAL | 1 0.01 43.94 ELECTROLYTE SUBSTITUTION THERAPY | 2 0.02 43.96 EMPHYSEMA | 46 0.46 44.42 ENCEPHALITIS | 1 0.01 44.43 ENCEPHALITIS LETHARGICA | 6 0.06 44.49 ENDOMETRIOSIS | 2 0.02 44.51 ENDOSCOPY | 1 0.01 44.52 ENTERAL NUTRITION | 2 0.02 44.54 ENTEROCOCCAL INFECTION | 1 0.01 44.55 ENTEROCOLITIS | 2 0.02 44.57 ENURESIS | 1 0.01 44.58 EPENDYMOMA MALIGNANT | 1 0.01 44.59 EPIDURAL ANAESTHESIA | 1 0.01 44.60 EPILEPSY | 69 0.69 45.29 ERECTILE DYSFUNCTION | 27 0.27 45.56 ERYSIPELAS | 3 0.03 45.59 ESCHERICHIA INFECTION | 3 0.03 45.62 ESSENTIAL HYPERTENSION | 9 0.09 45.71 ESSENTIAL TREMOR | 1 0.01 45.72 EVANS SYNDROME | 2 0.02 45.74 EVIDENCE BASED TREATMENT | 2 0.02 45.76 EX-SMOKER | 4 0.04 45.80 EXOSTOSIS | 1 0.01 45.81 EXTRANODAL NK/T-CELL LYMPHOMA, NASAL .. | 5 0.05 45.86 EYE DISORDER | 1 0.01 45.87 EYE IRRIGATION | 10 0.10 45.97 EYE IRRITATION | 3 0.03 46.00 EYE OPERATION | 4 0.04 46.04 FABRY'S DISEASE | 3 0.03 46.07 FACIAL NEURALGIA | 1 0.01 46.08 FACIAL PAIN | 2 0.02 46.10 FACTOR VIII DEFICIENCY | 3 0.03 46.13 FALLOPIAN TUBE CANCER | 3 0.03 46.16 FATIGUE | 2 0.02 46.18 FEBRILE CONVULSION | 1 0.01 46.19 FEBRILE INFECTION | 3 0.03 46.22 FEBRILE NEUTROPENIA | 12 0.12 46.34 FEELING OF RELAXATION | 1 0.01 46.35 FIBROMYALGIA | 20 0.20 46.55 FLUID RETENTION | 4 0.04 46.59 FOLATE DEFICIENCY | 1 0.01 46.60 FOOD ALLERGY | 2 0.02 46.62 FOOT FRACTURE | 1 0.01 46.63 FOREIGN BODY IN EYE | 1 0.01 46.64 FRACTURE | 2 0.02 46.66 FRACTURE TREATMENT | 2 0.02 46.68 FUNGAL INFECTION | 7 0.07 46.75 FUNGAL SKIN INFECTION | 2 0.02 46.77 GAIT DISTURBANCE | 2 0.02 46.79 GALLBLADDER CANCER | 1 0.01 46.80 GALLBLADDER CANCER NON-RESECTABLE | 1 0.01 46.81 GALLBLADDER CANCER STAGE IV | 1 0.01 46.82 GASTRECTOMY | 1 0.01 46.83 GASTRIC CANCER | 4 0.04 46.87 GASTRIC DISORDER | 3 0.03 46.90 GASTRIC NEOPLASM | 1 0.01 46.91 GASTRIC PH DECREASED | 1 0.01 46.92 GASTRIC ULCER | 14 0.14 47.06 GASTRITIS | 22 0.22 47.28 GASTRITIS PROPHYLAXIS | 4 0.04 47.32 GASTROINTESTINAL CARCINOMA | 2 0.02 47.34 GASTROINTESTINAL DISORDER | 5 0.05 47.39 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 47.40 GASTROINTESTINAL HAEMORRHAGE | 4 0.04 47.44 GASTROINTESTINAL INFECTION | 1 0.01 47.45 GASTROINTESTINAL OBSTRUCTION | 1 0.01 47.46 GASTROINTESTINAL SCAN | 2 0.02 47.48 GASTROINTESTINAL STROMAL TUMOUR | 3 0.03 47.51 GASTROOESOPHAGEAL REFLUX DISEASE | 51 0.51 48.02 GAUCHER'S DISEASE | 3 0.03 48.05 GENERAL ANAESTHESIA | 7 0.07 48.12 GENERALISED ANXIETY DISORDER | 4 0.04 48.16 GERM CELL CANCER | 8 0.08 48.24 GINGIVAL INFECTION | 1 0.01 48.25 GINGIVITIS | 1 0.01 48.26 GLAUCOMA | 6 0.06 48.32 GLIOBLASTOMA | 1 0.01 48.33 GLIOBLASTOMA MULTIFORME | 12 0.12 48.45 GLIOMA | 3 0.03 48.48 GLOMERULONEPHRITIS | 2 0.02 48.50 GLOMERULONEPHRITIS MEMBRANOUS | 3 0.03 48.53 GLYCOGEN STORAGE DISEASE TYPE II | 5 0.05 48.58 GOITRE | 3 0.03 48.61 GOUT | 5 0.05 48.66 GOUTY ARTHRITIS | 1 0.01 48.67 GRAFT VERSUS HOST DISEASE | 3 0.03 48.70 GRAND MAL CONVULSION | 2 0.02 48.72 GROIN INFECTION | 1 0.01 48.73 GROWTH HORMONE DEFICIENCY | 5 0.05 48.78 HABITUAL ABORTION | 1 0.01 48.79 HAEMODIALYSIS | 4 0.04 48.83 HAEMOGLOBIN DECREASED | 2 0.02 48.85 HAEMOPHILIA | 2 0.02 48.87 HAEMOPHILIA A WITH ANTI FACTOR VIII | 1 0.01 48.88 HAEMORRHAGE | 1 0.01 48.89 HAEMOSIDEROSIS | 1 0.01 48.90 HAEMOSTASIS | 1 0.01 48.91 HALLUCINATION | 2 0.02 48.93 HEADACHE | 29 0.29 49.22 HEART RATE | 1 0.01 49.23 HEART RATE IRREGULAR | 3 0.03 49.26 HEART TRANSPLANT | 6 0.06 49.32 HEART VALVE REPLACEMENT | 1 0.01 49.33 HELICOBACTER INFECTION | 3 0.03 49.36 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 49.37 HEPATIC CANCER METASTATIC | 3 0.03 49.40 HEPATIC FUNCTION ABNORMAL | 1 0.01 49.41 HEPATIC NEOPLASM MALIGNANT | 6 0.06 49.47 HEPATITIS B | 16 0.16 49.63 HEPATITIS B VIRUS | 1 0.01 49.64 HEPATITIS C | 61 0.61 50.25 HEPATITIS C VIRUS | 1 0.01 50.26 HEPATITIS FULMINANT | 1 0.01 50.27 HEREDITARY HAEMORRHAGIC TELANGIECTASIA | 1 0.01 50.28 HERNIA | 1 0.01 50.29 HERPES SIMPLEX | 1 0.01 50.30 HERPES VIRUS INFECTION | 1 0.01 50.31 HERPES ZOSTER | 25 0.25 50.56 HIATUS HERNIA | 3 0.03 50.59 HIP ARTHROPLASTY | 1 0.01 50.60 HISTAMINE LEVEL | 1 0.01 50.61 HISTOPLASMOSIS | 1 0.01 50.62 HIV INFECTION | 199 1.99 52.61 HIV TEST POSITIVE | 16 0.16 52.77 HORMONE REPLACEMENT THERAPY | 24 0.24 53.01 HORMONE THERAPY | 2 0.02 53.03 HOT FLUSH | 6 0.06 53.09 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 1 0.01 53.10 HYPERCHLORHYDRIA | 1 0.01 53.11 HYPERCHOLESTEROLAEMIA | 45 0.45 53.56 HYPEREMESIS GRAVIDARUM | 4 0.04 53.60 HYPERGLYCAEMIA | 1 0.01 53.61 HYPERKALAEMIA | 2 0.02 53.63 HYPERKINESIA | 1 0.01 53.64 HYPERLIPIDAEMIA | 39 0.39 54.03 HYPERPARATHYROIDISM SECONDARY | 4 0.04 54.07 HYPERPHOSPHATAEMIA | 2 0.02 54.09 HYPERSENSITIVITY | 12 0.12 54.21 HYPERTENSION | 457 4.57 58.78 HYPERTHYROIDISM | 3 0.03 58.81 HYPERTONIA | 2 0.02 58.83 HYPERTONIC BLADDER | 4 0.04 58.87 HYPERTRIGLYCERIDAEMIA | 2 0.02 58.89 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 58.90 HYPERURICAEMIA | 5 0.05 58.95 HYPOAESTHESIA | 1 0.01 58.96 HYPOALBUMINAEMIA | 1 0.01 58.97 HYPOGAMMAGLOBULINAEMIA | 1 0.01 58.98 HYPOGLYCAEMIA | 1 0.01 58.99 HYPOKALAEMIA | 2 0.02 59.01 HYPOMAGNESAEMIA | 1 0.01 59.02 HYPOMANIA | 1 0.01 59.03 HYPOPHARYNGEAL CANCER | 4 0.04 59.07 HYPOPITUITARISM | 8 0.08 59.15 HYPOTENSION | 5 0.05 59.20 HYPOTHALAMO-PITUITARY DISORDER | 1 0.01 59.21 HYPOTHYROIDISM | 31 0.31 59.52 HYPOTONIA | 1 0.01 59.53 HYPOVITAMINOSIS | 1 0.01 59.54 IDIOPATHIC PULMONARY FIBROSIS | 3 0.03 59.57 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 59.58 ILL-DEFINED DISORDER | 2 0.02 59.60 IMMUNODEFICIENCY COMMON VARIABLE | 1 0.01 59.61 IMMUNOSUPPRESSION | 11 0.11 59.72 IMPAIRED GASTRIC EMPTYING | 1 0.01 59.73 IMPULSIVE BEHAVIOUR | 1 0.01 59.74 INCONTINENCE | 1 0.01 59.75 INDUCTION OF ANAESTHESIA | 3 0.03 59.78 INFANTILE SPASMS | 1 0.01 59.79 INFECTION | 35 0.35 60.14 INFECTION PROPHYLAXIS | 16 0.16 60.30 INFERTILITY | 3 0.03 60.33 INFLAMMATION | 2 0.02 60.35 INFLAMMATORY BOWEL DISEASE | 1 0.01 60.36 INFLUENZA | 17 0.17 60.53 INFLUENZA IMMUNISATION | 1 0.01 60.54 INFLUENZA LIKE ILLNESS | 3 0.03 60.57 INJURY | 1 0.01 60.58 INSOMNIA | 67 0.67 61.25 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 11 0.11 61.36 INSULINOMA | 1 0.01 61.37 INTENTIONAL OVERDOSE | 4 0.04 61.41 INTERMITTENT CLAUDICATION | 1 0.01 61.42 INTERSTITIAL LUNG DISEASE | 1 0.01 61.43 INTERVERTEBRAL DISC DEGENERATION | 3 0.03 61.46 INTERVERTEBRAL DISC DISORDER | 3 0.03 61.49 INTERVERTEBRAL DISC PROTRUSION | 4 0.04 61.53 INTRA-ABDOMINAL HAEMORRHAGE | 1 0.01 61.54 INTRAOCULAR PRESSURE TEST | 2 0.02 61.56 INTRAOCULAR PRESSURE TEST ABNORMAL | 1 0.01 61.57 IRON DEFICIENCY | 5 0.05 61.62 IRON DEFICIENCY ANAEMIA | 2 0.02 61.64 IRON OVERLOAD | 4 0.04 61.68 IRRITABLE BOWEL SYNDROME | 2 0.02 61.70 ISCHAEMIA | 2 0.02 61.72 ISCHAEMIC CARDIOMYOPATHY | 2 0.02 61.74 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 8 0.08 61.82 ISCHAEMIC STROKE | 3 0.03 61.85 ISOLATED ADRENOCORTICOTROPIC HORMONE .. | 2 0.02 61.87 JOINT EFFUSION | 1 0.01 61.88 JOINT INJURY | 1 0.01 61.89 JUVENILE ARTHRITIS | 10 0.10 61.99 KAPOSI'S SARCOMA | 4 0.04 62.03 KERATITIS BACTERIAL | 1 0.01 62.04 KYPHOSIS | 2 0.02 62.06 LABOUR INDUCTION | 1 0.01 62.07 LACUNAR INFARCTION | 2 0.02 62.09 LARGE INTESTINE CARCINOMA | 2 0.02 62.11 LATENT TUBERCULOSIS | 3 0.03 62.14 LAXATIVE SUPPORTIVE CARE | 1 0.01 62.15 LEIOMYOSARCOMA | 1 0.01 62.16 LENNOX-GASTAUT SYNDROME | 1 0.01 62.17 LEUKAEMIA | 1 0.01 62.18 LEUKOCYTOSIS | 1 0.01 62.19 LIPIDS ABNORMAL | 1 0.01 62.20 LIPIDS INCREASED | 2 0.02 62.22 LIVER ABSCESS | 4 0.04 62.26 LIVER DISORDER | 1 0.01 62.27 LIVER TRANSPLANT | 9 0.09 62.36 LOBAR PNEUMONIA | 4 0.04 62.40 LOCAL ANAESTHESIA | 1 0.01 62.41 LOCALISED INFECTION | 1 0.01 62.42 LOW DENSITY LIPOPROTEIN DECREASED | 1 0.01 62.43 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 62.44 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 62.47 LUMBAR SPINAL STENOSIS | 2 0.02 62.49 LUNG ADENOCARCINOMA | 1 0.01 62.50 LUNG ADENOCARCINOMA STAGE IV | 3 0.03 62.53 LUNG CANCER METASTATIC | 1 0.01 62.54 LUNG DISORDER | 8 0.08 62.62 LUNG INFECTION | 1 0.01 62.63 LUNG NEOPLASM MALIGNANT | 19 0.19 62.82 LUNG TRANSPLANT | 4 0.04 62.86 LUNG TRANSPLANT REJECTION | 1 0.01 62.87 LUPUS NEPHRITIS | 3 0.03 62.90 LYME DISEASE | 1 0.01 62.91 LYMPHOCYTIC HYPOPHYSITIS | 1 0.01 62.92 LYMPHOMA | 23 0.23 63.15 LYMPHOPROLIFERATIVE DISORDER | 3 0.03 63.18 MACULAR DEGENERATION | 6 0.06 63.24 MAINTENANCE OF ANAESTHESIA | 1 0.01 63.25 MAJOR DEPRESSION | 30 0.30 63.55 MALAISE | 1 0.01 63.56 MALARIA | 1 0.01 63.57 MALARIA PROPHYLAXIS | 6 0.06 63.63 MALIGNANT FIBROUS HISTIOCYTOMA | 1 0.01 63.64 MALIGNANT GLIOMA | 1 0.01 63.65 MALIGNANT MELANOMA | 12 0.12 63.77 MALIGNANT PALATE NEOPLASM | 2 0.02 63.79 MALNUTRITION | 1 0.01 63.80 MANIA | 4 0.04 63.84 MANTLE CELL LYMPHOMA | 2 0.02 63.86 MEDICAL DIET | 8 0.08 63.94 MENINGEAL DISORDER | 4 0.04 63.98 MENINGITIS | 4 0.04 64.02 MENINGITIS BACTERIAL | 2 0.02 64.04 MENINGOCOCCAL SEPSIS | 2 0.02 64.06 MENOMETRORRHAGIA | 2 0.02 64.08 MENOPAUSAL SYMPTOMS | 3 0.03 64.11 MENOPAUSE | 19 0.19 64.30 MENORRHAGIA | 5 0.05 64.35 MENSTRUAL CYCLE MANAGEMENT | 1 0.01 64.36 MENSTRUAL DISORDER | 3 0.03 64.39 MENSTRUATION IRREGULAR | 11 0.11 64.50 MENTAL DISORDER | 8 0.08 64.58 MENTAL IMPAIRMENT | 1 0.01 64.59 MESOTHELIOMA | 1 0.01 64.60 METASTASES TO BONE | 12 0.12 64.72 METASTASES TO CENTRAL NERVOUS SYSTEM | 3 0.03 64.75 METASTASES TO LIVER | 2 0.02 64.77 METASTATIC GASTRIC CANCER | 9 0.09 64.86 METASTATIC MALIGNANT MELANOMA | 2 0.02 64.88 METASTATIC RENAL CELL CARCINOMA | 10 0.10 64.98 MICROSPORUM INFECTION | 1 0.01 64.99 MIGRAINE | 20 0.20 65.19 MIGRAINE PROPHYLAXIS | 7 0.07 65.26 MINERAL SUPPLEMENTATION | 8 0.08 65.34 MITRAL VALVE PROLAPSE | 2 0.02 65.36 MITRAL VALVE REPLACEMENT | 1 0.01 65.37 MIXED CONNECTIVE TISSUE DISEASE | 3 0.03 65.40 MIXED HYPERLIPIDAEMIA | 2 0.02 65.42 MOOD ALTERED | 1 0.01 65.43 MOUTH ULCERATION | 3 0.03 65.46 MUCOCUTANEOUS CANDIDIASIS | 1 0.01 65.47 MUCOPOLYSACCHARIDOSIS I | 1 0.01 65.48 MUCOPOLYSACCHARIDOSIS VI | 1 0.01 65.49 MUCOSAL DISCOLOURATION | 1 0.01 65.50 MUCOSAL INFLAMMATION | 2 0.02 65.52 MULTI-ORGAN FAILURE | 1 0.01 65.53 MULTIPLE ALLERGIES | 7 0.07 65.60 MULTIPLE MYELOMA | 75 0.75 66.35 MULTIPLE SCLEROSIS | 175 1.75 68.10 MULTIPLE SCLEROSIS RELAPSE | 2 0.02 68.12 MUSCLE ABSCESS | 4 0.04 68.16 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 68.17 MUSCLE RELAXANT THERAPY | 5 0.05 68.22 MUSCLE SPASMS | 10 0.10 68.32 MUSCLE SPASTICITY | 9 0.09 68.41 MUSCLE STRAIN | 1 0.01 68.42 MUSCULOSKELETAL PAIN | 11 0.11 68.53 MYALGIA | 2 0.02 68.55 MYASTHENIA GRAVIS | 3 0.03 68.58 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 68.59 MYCOSIS FUNGOIDES | 2 0.02 68.61 MYDRIASIS | 3 0.03 68.64 MYELODYSPLASTIC SYNDROME | 13 0.13 68.77 MYELOID METAPLASIA | 2 0.02 68.79 MYOCARDIAL INFARCTION | 12 0.12 68.91 MYOCARDIAL ISCHAEMIA | 19 0.19 69.10 NAIL INFECTION | 1 0.01 69.11 NARCOLEPSY | 1 0.01 69.12 NASAL CONGESTION | 3 0.03 69.15 NASOPHARYNGEAL CANCER | 6 0.06 69.21 NASOPHARYNGITIS | 53 0.53 69.74 NAUSEA | 21 0.21 69.95 NECK PAIN | 4 0.04 69.99 NEOPLASM MALIGNANT | 23 0.23 70.22 NEOPLASM PROPHYLAXIS | 1 0.01 70.23 NEPHROGENIC ANAEMIA | 1 0.01 70.24 NEPHROPATHY | 1 0.01 70.25 NERVE COMPRESSION | 1 0.01 70.26 NERVE INJURY | 3 0.03 70.29 NERVOUSNESS | 2 0.02 70.31 NEURALGIA | 21 0.21 70.52 NEUROBLASTOMA | 2 0.02 70.54 NEUROENDOCRINE CARCINOMA | 2 0.02 70.56 NEUROGENIC BLADDER | 1 0.01 70.57 NEUROPATHIC ULCER | 1 0.01 70.58 NEUROPATHY PERIPHERAL | 13 0.13 70.71 NEUROSIS | 1 0.01 70.72 NEUTROPENIA | 4 0.04 70.76 NEUTROPHIL COUNT DECREASED | 1 0.01 70.77 NICOTINE DEPENDENCE | 2 0.02 70.79 NOCTURIA | 2 0.02 70.81 NON-HODGKIN'S LYMPHOMA | 18 0.18 70.99 NON-SMALL CELL LUNG CANCER | 68 0.68 71.67 NUCLEAR MAGNETIC RESONANCE IMAGING | 11 0.11 71.78 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 3 0.03 71.81 NUTRITIONAL SUPPORT | 1 0.01 71.82 OBESITY | 12 0.12 71.94 OBSESSIVE-COMPULSIVE DISORDER | 16 0.16 72.10 OCULAR HYPERAEMIA | 1 0.01 72.11 OCULAR ICTERUS | 1 0.01 72.12 OEDEMA | 2 0.02 72.14 OEDEMA PERIPHERAL | 3 0.03 72.17 OESOPHAGEAL CANDIDIASIS | 4 0.04 72.21 OESOPHAGEAL CARCINOMA | 3 0.03 72.24 OESOPHAGEAL OEDEMA | 1 0.01 72.25 OESOPHAGITIS | 2 0.02 72.27 OESTROGEN REPLACEMENT THERAPY | 3 0.03 72.30 OFF LABEL USE | 1 0.01 72.31 OFFICE VISIT | 1 0.01 72.32 ONCHOCERCIASIS | 1 0.01 72.33 ONYCHOMYCOSIS | 9 0.09 72.42 OPPORTUNISTIC INFECTION PROPHYLAXIS | 2 0.02 72.44 ORAL CANDIDIASIS | 1 0.01 72.45 ORAL CONTRACEPTION | 69 0.69 73.14 ORAL FUNGAL INFECTION | 2 0.02 73.16 ORAL INFECTION | 1 0.01 73.17 ORAL PAIN | 3 0.03 73.20 ORAL SURGERY | 3 0.03 73.23 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 3 0.03 73.26 ORTHOPEDIC PROCEDURE | 2 0.02 73.28 OSTEITIS | 4 0.04 73.32 OSTEITIS DEFORMANS | 1 0.01 73.33 OSTEOARTHRITIS | 17 0.17 73.50 OSTEOMYELITIS | 4 0.04 73.54 OSTEOPENIA | 16 0.16 73.70 OSTEOPOROSIS | 187 1.87 75.57 OSTEOPOROSIS POSTMENOPAUSAL | 8 0.08 75.65 OSTEOPOROSIS PROPHYLAXIS | 7 0.07 75.72 OSTEOPOROTIC FRACTURE | 15 0.15 75.87 OSTEOSARCOMA METASTATIC | 2 0.02 75.89 OTITIS EXTERNA | 1 0.01 75.90 OTITIS MEDIA | 3 0.03 75.93 OTITIS MEDIA ACUTE | 1 0.01 75.94 OVARIAN CANCER | 16 0.16 76.10 OVARIAN CYST | 3 0.03 76.13 OVARIAN EPITHELIAL CANCER | 2 0.02 76.15 OVERDOSE | 1 0.01 76.16 OVERWEIGHT | 1 0.01 76.17 PAIN | 197 1.97 78.14 PAIN IN EXTREMITY | 18 0.18 78.32 PAIN MANAGEMENT | 1 0.01 78.33 PAIN OF SKIN | 1 0.01 78.34 PAIN PROPHYLAXIS | 4 0.04 78.38 PANCREATIC CARCINOMA | 11 0.11 78.49 PANCREATIC CARCINOMA METASTATIC | 2 0.02 78.51 PANCREATIC CARCINOMA NON-RESECTABLE | 4 0.04 78.55 PANCREATITIS | 2 0.02 78.57 PANCREATITIS ACUTE | 1 0.01 78.58 PANIC ATTACK | 6 0.06 78.64 PANIC DISORDER | 6 0.06 78.70 PANIC REACTION | 1 0.01 78.71 PANNICULITIS | 1 0.01 78.72 PARAESTHESIA | 3 0.03 78.75 PARANOIA | 3 0.03 78.78 PARKINSON'S DISEASE | 71 0.71 79.49 PARKINSONISM | 6 0.06 79.55 PARTIAL SEIZURES | 8 0.08 79.63 PELVIC FLOOR MUSCLE WEAKNESS | 1 0.01 79.64 PELVIC FRACTURE | 1 0.01 79.65 PEMPHIGUS | 2 0.02 79.67 PENILE OEDEMA | 1 0.01 79.68 PEPTIC ULCER | 2 0.02 79.70 PERCUTANEOUS CORONARY INTERVENTION | 6 0.06 79.76 PERIODONTITIS | 2 0.02 79.78 PERIOPERATIVE ANALGESIA | 1 0.01 79.79 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 2 0.02 79.81 PERIPHERAL BLOOD STEM CELL APHERESIS | 1 0.01 79.82 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED | 8 0.08 79.90 PERIPHERAL VASCULAR DISORDER | 1 0.01 79.91 PERITONEAL CARCINOMA | 1 0.01 79.92 PERITONEAL DIALYSIS | 19 0.19 80.11 PERSONALITY DISORDER | 1 0.01 80.12 PETIT MAL EPILEPSY | 1 0.01 80.13 PHARYNGEAL CANCER STAGE UNSPECIFIED | 2 0.02 80.15 PHARYNGEAL DISORDER | 1 0.01 80.16 PHARYNGITIS | 1 0.01 80.17 PHARYNGITIS STREPTOCOCCAL | 1 0.01 80.18 PHARYNGOLARYNGEAL PAIN | 5 0.05 80.23 PHLEBITIS | 3 0.03 80.26 PLANTAR FASCIITIS | 1 0.01 80.27 PLASMACYTOMA | 1 0.01 80.28 PLATELET AGGREGATION | 2 0.02 80.30 PLEURAL EFFUSION | 1 0.01 80.31 PLEURAL MESOTHELIOMA | 2 0.02 80.33 PLEURAL MESOTHELIOMA MALIGNANT | 10 0.10 80.43 PLEURAL MESOTHELIOMA MALIGNANT RECURR.. | 2 0.02 80.45 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 80.46 PNEUMOCYSTIS JIROVECI PNEUMONIA | 2 0.02 80.48 PNEUMONIA | 41 0.41 80.89 PNEUMONIA ASPIRATION | 1 0.01 80.90 PNEUMONIA LEGIONELLA | 1 0.01 80.91 PNEUMONIA STAPHYLOCOCCAL | 2 0.02 80.93 POLLAKIURIA | 1 0.01 80.94 POLYARTHRITIS | 8 0.08 81.02 POLYCYSTIC OVARIES | 8 0.08 81.10 POLYMYALGIA RHEUMATICA | 3 0.03 81.13 POLYMYOSITIS | 1 0.01 81.14 POLYURIA | 2 0.02 81.16 POST HERPETIC NEURALGIA | 2 0.02 81.18 POST PROCEDURAL COMPLICATION | 1 0.01 81.19 POST-TRAUMATIC STRESS DISORDER | 12 0.12 81.31 POSTOPERATIVE CARE | 20 0.20 81.51 POSTOPERATIVE WOUND INFECTION | 1 0.01 81.52 POSTPARTUM HAEMORRHAGE | 2 0.02 81.54 PRE-EXISTING DISEASE | 1 0.01 81.55 PREGNANCY | 5 0.05 81.60 PREGNANCY INDUCED HYPERTENSION | 4 0.04 81.64 PREMATURE MENOPAUSE | 1 0.01 81.65 PREMEDICATION | 32 0.32 81.97 PREMENSTRUAL SYNDROME | 12 0.12 82.09 PREOPERATIVE CARE | 20 0.20 82.29 PROCEDURAL PAIN | 7 0.07 82.36 PROCTALGIA | 2 0.02 82.38 PRODUCTIVE COUGH | 3 0.03 82.41 PROPHYLAXIS | 105 1.05 83.46 PROPHYLAXIS AGAINST DEHYDRATION | 1 0.01 83.47 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 9 0.09 83.56 PROPHYLAXIS AGAINST HIV INFECTION | 4 0.04 83.60 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 33 0.33 83.93 PROPHYLAXIS OF NAUSEA AND VOMITING | 6 0.06 83.99 PROSTATE CANCER | 21 0.21 84.20 PROSTATIC DISORDER | 2 0.02 84.22 PROSTATIC SPECIFIC ANTIGEN INCREASED | 1 0.01 84.23 PROSTATISM | 1 0.01 84.24 PROSTATITIS | 3 0.03 84.27 PROSTATOMEGALY | 4 0.04 84.31 PRURIGO | 4 0.04 84.35 PRURITUS | 13 0.13 84.48 PSEUDOMONAS INFECTION | 3 0.03 84.51 PSOAS ABSCESS | 4 0.04 84.55 PSORIASIS | 38 0.38 84.93 PSORIATIC ARTHROPATHY | 28 0.28 85.21 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 85.22 PSYCHOTIC BEHAVIOUR | 1 0.01 85.23 PSYCHOTIC DISORDER | 15 0.15 85.38 PULMONARY EMBOLISM | 10 0.10 85.48 PULMONARY FIBROSIS | 2 0.02 85.50 PULMONARY HYPERTENSION | 30 0.30 85.80 PURPURA FULMINANS | 1 0.01 85.81 PYELONEPHRITIS | 3 0.03 85.84 PYODERMA GANGRENOSUM | 2 0.02 85.86 PYREXIA | 29 0.29 86.15 RADIATION PNEUMONITIS | 1 0.01 86.16 RADICULAR PAIN | 1 0.01 86.17 RAPID EYE MOVEMENTS SLEEP ABNORMAL | 1 0.01 86.18 RASH | 15 0.15 86.33 RAYNAUD'S PHENOMENON | 2 0.02 86.35 RECTAL CANCER | 21 0.21 86.56 RECTAL CANCER RECURRENT | 4 0.04 86.60 RECTOSIGMOID CANCER | 3 0.03 86.63 REFLUX OESOPHAGITIS | 9 0.09 86.72 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 10 0.10 86.82 RENAL ARTERY STENOSIS | 1 0.01 86.83 RENAL CANCER METASTATIC | 2 0.02 86.85 RENAL CELL CARCINOMA | 11 0.11 86.96 RENAL FAILURE | 1 0.01 86.97 RENAL FAILURE CHRONIC | 15 0.15 87.12 RENAL TRANSPLANT | 37 0.37 87.49 RESPIRATORY DISORDER | 3 0.03 87.52 RESPIRATORY DISTRESS | 1 0.01 87.53 RESPIRATORY FAILURE | 1 0.01 87.54 RESPIRATORY TRACT INFECTION | 9 0.09 87.63 RESTLESS LEGS SYNDROME | 36 0.36 87.99 RESTLESSNESS | 2 0.02 88.01 RHABDOMYOSARCOMA | 1 0.01 88.02 RHEUMATOID ARTHRITIS | 345 3.45 91.47 RHINITIS | 1 0.01 91.48 RHINITIS ALLERGIC | 5 0.05 91.53 RHINORRHOEA | 1 0.01 91.54 ROSACEA | 5 0.05 91.59 ROUTINE HEALTH MAINTENANCE | 7 0.07 91.66 SARCOMA | 2 0.02 91.68 SCAN MYOCARDIAL PERFUSION | 1 0.01 91.69 SCAN WITH CONTRAST | 2 0.02 91.71 SCHIZOAFFECTIVE DISORDER | 7 0.07 91.78 SCHIZOPHRENIA | 62 0.62 92.40 SCHIZOPHRENIA, PARANOID TYPE | 1 0.01 92.41 SCIATICA | 3 0.03 92.44 SCLERODERMA | 3 0.03 92.47 SEASONAL ALLERGY | 4 0.04 92.51 SEBORRHOEA | 1 0.01 92.52 SECONDARY HYPOTHYROIDISM | 4 0.04 92.56 SEDATION | 9 0.09 92.65 SEDATIVE THERAPY | 1 0.01 92.66 SEIZURE ANOXIC | 1 0.01 92.67 SELF INJURIOUS BEHAVIOUR | 1 0.01 92.68 SENILE DEMENTIA | 2 0.02 92.70 SENSITIVITY OF TEETH | 1 0.01 92.71 SEPSIS | 5 0.05 92.76 SEPSIS NEONATAL | 2 0.02 92.78 SEPTIC SHOCK | 4 0.04 92.82 SICK SINUS SYNDROME | 1 0.01 92.83 SICKLE CELL ANAEMIA | 3 0.03 92.86 SINUS DISORDER | 5 0.05 92.91 SINUS POLYP | 3 0.03 92.94 SINUSITIS | 26 0.26 93.20 SJOGREN'S SYNDROME | 3 0.03 93.23 SKIN CANCER | 2 0.02 93.25 SKIN CANCER METASTATIC | 1 0.01 93.26 SKIN DISORDER | 1 0.01 93.27 SKIN INFECTION | 2 0.02 93.29 SKIN REACTION | 1 0.01 93.30 SKIN ULCER | 1 0.01 93.31 SKIN WRINKLING | 1 0.01 93.32 SLEEP APNOEA SYNDROME | 1 0.01 93.33 SLEEP DISORDER | 22 0.22 93.55 SLEEP DISORDER THERAPY | 2 0.02 93.57 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 4 0.04 93.61 SMOKER | 2 0.02 93.63 SMOKING CESSATION THERAPY | 131 1.31 94.94 SOCIAL PHOBIA | 1 0.01 94.95 SOMNOLENCE | 1 0.01 94.96 SPINAL ANAESTHESIA | 1 0.01 94.97 SPINAL COMPRESSION FRACTURE | 1 0.01 94.98 SPINAL CORD INJURY | 1 0.01 94.99 SPINAL OSTEOARTHRITIS | 4 0.04 95.03 SPINOCEREBELLAR ATAXIA | 1 0.01 95.04 SPIROMETRY ABNORMAL | 1 0.01 95.05 SPONDYLITIS | 2 0.02 95.07 SPONDYLOARTHROPATHY | 1 0.01 95.08 SPUTUM DISCOLOURED | 1 0.01 95.09 SQUAMOUS CELL CARCINOMA | 30 0.30 95.39 STAPHYLOCOCCAL INFECTION | 9 0.09 95.48 STAPHYLOCOCCAL SEPSIS | 1 0.01 95.49 STEM CELL TRANSPLANT | 23 0.23 95.72 STENT PLACEMENT | 5 0.05 95.77 STOMACH DISCOMFORT | 8 0.08 95.85 STOMATITIS | 4 0.04 95.89 STRESS | 12 0.12 96.01 STRESS ECHOCARDIOGRAM | 4 0.04 96.05 SUICIDAL IDEATION | 1 0.01 96.06 SUICIDE ATTEMPT | 2 0.02 96.08 SUPPLEMENTATION THERAPY | 16 0.16 96.24 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 96.25 SURGERY | 5 0.05 96.30 SWEAT GLAND INFECTION | 1 0.01 96.31 SWELLING | 1 0.01 96.32 SYSTEMIC ANTIFUNGAL TREATMENT | 2 0.02 96.34 SYSTEMIC CANDIDA | 1 0.01 96.35 SYSTEMIC LUPUS ERYTHEMATOSUS | 10 0.10 96.45 SYSTEMIC SCLEROSIS | 6 0.06 96.51 T-CELL LYMPHOMA | 5 0.05 96.56 TACHYCARDIA | 4 0.04 96.60 TACHYCARDIA PAROXYSMAL | 1 0.01 96.61 TEARFULNESS | 1 0.01 96.62 TENOSYNOVITIS | 2 0.02 96.64 TENSION HEADACHE | 1 0.01 96.65 TESTICULAR GERM CELL CANCER | 7 0.07 96.72 TESTICULAR NEOPLASM | 4 0.04 96.76 THALASSAEMIA | 1 0.01 96.77 THERAPEUTIC AGENT TOXICITY | 1 0.01 96.78 THERAPEUTIC RESPONSE DECREASED | 2 0.02 96.80 THERMAL BURN | 1 0.01 96.81 THROMBOSIS | 3 0.03 96.84 THROMBOSIS PROPHYLAXIS | 37 0.37 97.21 THYMOMA | 3 0.03 97.24 THYROID CANCER | 1 0.01 97.25 THYROID DISORDER | 12 0.12 97.37 THYROID OPERATION | 1 0.01 97.38 TIC | 1 0.01 97.39 TINEA CRURIS | 1 0.01 97.40 TOBACCO ABUSE | 2 0.02 97.42 TOBACCO USER | 1 0.01 97.43 TONGUE ULCERATION | 1 0.01 97.44 TONSILLECTOMY | 3 0.03 97.47 TOOTH ABSCESS | 2 0.02 97.49 TOOTH INFECTION | 1 0.01 97.50 TOOTHACHE | 5 0.05 97.55 TRANSIENT ACANTHOLYTIC DERMATOSIS | 1 0.01 97.56 TRANSIENT ISCHAEMIC ATTACK | 2 0.02 97.58 TRANSITIONAL CELL CARCINOMA | 2 0.02 97.60 TRANSPLANT | 1 0.01 97.61 TRAUMATIC HAEMORRHAGE | 3 0.03 97.64 TREMOR | 3 0.03 97.67 TRICHOSPORON INFECTION | 1 0.01 97.68 TRIGEMINAL NEURALGIA | 5 0.05 97.73 TROPONIN INCREASED | 1 0.01 97.74 TUBERCULIN TEST POSITIVE | 1 0.01 97.75 TUBERCULOSIS | 4 0.04 97.79 TURNER'S SYNDROME | 1 0.01 97.80 TYPE 1 DIABETES MELLITUS | 18 0.18 97.98 TYPE 2 DIABETES MELLITUS | 52 0.52 98.50 TYROSINAEMIA | 1 0.01 98.51 ULCER | 4 0.04 98.55 UNEVALUABLE EVENT | 8 0.08 98.63 UNRELATED DONOR BONE MARROW TRANSPLAN.. | 5 0.05 98.68 UPPER RESPIRATORY TRACT INFECTION | 6 0.06 98.74 UPPER RESPIRATORY TRACT INFLAMMATION | 4 0.04 98.78 URINARY HESITATION | 1 0.01 98.79 URINARY INCONTINENCE | 4 0.04 98.83 URINARY TRACT DISORDER | 1 0.01 98.84 URINARY TRACT INFECTION | 29 0.29 99.13 URINE FLOW DECREASED | 1 0.01 99.14 URTICARIA | 1 0.01 99.15 UTERINE CANCER | 3 0.03 99.18 UTERINE HAEMORRHAGE | 1 0.01 99.19 UVEITIS | 3 0.03 99.22 VAGINAL HAEMORRHAGE | 1 0.01 99.23 VARICELLA | 1 0.01 99.24 VARICOSE VEIN | 1 0.01 99.25 VASCULAR DEMENTIA | 1 0.01 99.26 VASODILATATION | 1 0.01 99.27 VENOUS THROMBOSIS | 2 0.02 99.29 VENTRICULAR ASSIST DEVICE INSERTION | 1 0.01 99.30 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.31 VENTRICULAR FIBRILLATION | 1 0.01 99.32 VENTRICULAR TACHYCARDIA | 4 0.04 99.36 VERTEBRAL INJURY | 1 0.01 99.37 VERTEBROBASILAR INSUFFICIENCY | 1 0.01 99.38 VERTICAL INFECTION TRANSMISSION | 2 0.02 99.40 VITAMIN B12 DEFICIENCY | 1 0.01 99.41 VITAMIN SUPPLEMENTATION | 20 0.20 99.61 VOMITING | 10 0.10 99.71 WEGENER'S GRANULOMATOSIS | 4 0.04 99.75 WEIGHT CONTROL | 5 0.05 99.80 WEIGHT DECREASED | 1 0.01 99.81 WEIGHT LOSS DIET | 7 0.07 99.88 WHEEZING | 1 0.01 99.89 WHITE BLOOD CELL COUNT INCREASED | 1 0.01 99.90 WOUND | 1 0.01 99.91 WOUND INFECTION | 1 0.01 99.92 X-RAY | 2 0.02 99.94 X-RAY WITH CONTRAST LOWER GASTROINTES.. | 1 0.01 99.95 X-RAY WITH CONTRAST UPPER GASTROINTES.. | 5 0.05 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015